Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.

Bibliographic Details
Title: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
Authors: Fischer, Eric S., Böhm, Kerstin, Lydeard, John R., Yang, Haidi, Stadler, Michael B., Cavadini, Simone, Nagel, Jane, Serluca, Fabrizio, Acker, Vincent, Lingaraju, Gondichatnahalli M., Tichkule, Ritesh B., Schebesta, Michael, Forrester, William C., Schirle, Markus, Hassiepen, Ulrich, Ottl, Johannes, Hild, Marc, Beckwith, Rohan E. J., Harper, J. Wade, Jenkins, Jeremy L.
Source: Nature. 8/6/2014, Vol. 512 Issue 7512, p49-53. 5p.
Subjects: ANTINEOPLASTIC agents, THALIDOMIDE, CARRIER proteins, TERATOGENICITY testing, MULTIPLE myeloma treatment, THERAPEUTICS
Abstract: In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects. Despite the teratogenicity of thalidomide and its derivatives lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-associated dysplasia. IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4CRBN. Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide. The structure establishes that CRBN is a substrate receptor within CRL4CRBN and enantioselectively binds IMiDs. Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4CRBN. Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4CRBN while the ligase complex is recruiting IKZF1 or IKZF3 for degradation. This dual activity implies that small molecules can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins. [ABSTRACT FROM AUTHOR]
Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MAS Ultra - School Edition
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:ulh&genre=article&issn=00280836&ISBN=&volume=512&issue=7512&date=20140806&spage=49&pages=49-53&title=Nature&atitle=Structure%20of%20the%20DDB1-CRBN%20E3%20ubiquitin%20ligase%20in%20complex%20with%20thalidomide.&aulast=Fischer%2C%20Eric%20S.&id=DOI:10.1038/nature13527
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: ulh
DbLabel: MAS Ultra - School Edition
An: 97379289
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fischer%2C+Eric+S%2E%22">Fischer, Eric S.</searchLink><br /><searchLink fieldCode="AR" term="%22Böhm%2C+Kerstin%22">Böhm, Kerstin</searchLink><br /><searchLink fieldCode="AR" term="%22Lydeard%2C+John+R%2E%22">Lydeard, John R.</searchLink><br /><searchLink fieldCode="AR" term="%22Yang%2C+Haidi%22">Yang, Haidi</searchLink><br /><searchLink fieldCode="AR" term="%22Stadler%2C+Michael+B%2E%22">Stadler, Michael B.</searchLink><br /><searchLink fieldCode="AR" term="%22Cavadini%2C+Simone%22">Cavadini, Simone</searchLink><br /><searchLink fieldCode="AR" term="%22Nagel%2C+Jane%22">Nagel, Jane</searchLink><br /><searchLink fieldCode="AR" term="%22Serluca%2C+Fabrizio%22">Serluca, Fabrizio</searchLink><br /><searchLink fieldCode="AR" term="%22Acker%2C+Vincent%22">Acker, Vincent</searchLink><br /><searchLink fieldCode="AR" term="%22Lingaraju%2C+Gondichatnahalli+M%2E%22">Lingaraju, Gondichatnahalli M.</searchLink><br /><searchLink fieldCode="AR" term="%22Tichkule%2C+Ritesh+B%2E%22">Tichkule, Ritesh B.</searchLink><br /><searchLink fieldCode="AR" term="%22Schebesta%2C+Michael%22">Schebesta, Michael</searchLink><br /><searchLink fieldCode="AR" term="%22Forrester%2C+William+C%2E%22">Forrester, William C.</searchLink><br /><searchLink fieldCode="AR" term="%22Schirle%2C+Markus%22">Schirle, Markus</searchLink><br /><searchLink fieldCode="AR" term="%22Hassiepen%2C+Ulrich%22">Hassiepen, Ulrich</searchLink><br /><searchLink fieldCode="AR" term="%22Ottl%2C+Johannes%22">Ottl, Johannes</searchLink><br /><searchLink fieldCode="AR" term="%22Hild%2C+Marc%22">Hild, Marc</searchLink><br /><searchLink fieldCode="AR" term="%22Beckwith%2C+Rohan+E%2E+J%2E%22">Beckwith, Rohan E. J.</searchLink><br /><searchLink fieldCode="AR" term="%22Harper%2C+J%2E+Wade%22">Harper, J. Wade</searchLink><br /><searchLink fieldCode="AR" term="%22Jenkins%2C+Jeremy+L%2E%22">Jenkins, Jeremy L.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Nature%22">Nature</searchLink>. 8/6/2014, Vol. 512 Issue 7512, p49-53. 5p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22ANTINEOPLASTIC+agents%22">ANTINEOPLASTIC agents</searchLink><br /><searchLink fieldCode="DE" term="%22THALIDOMIDE%22">THALIDOMIDE</searchLink><br /><searchLink fieldCode="DE" term="%22CARRIER+proteins%22">CARRIER proteins</searchLink><br /><searchLink fieldCode="DE" term="%22TERATOGENICITY+testing%22">TERATOGENICITY testing</searchLink><br /><searchLink fieldCode="DE" term="%22MULTIPLE+myeloma+treatment%22">MULTIPLE myeloma treatment</searchLink><br /><searchLink fieldCode="DE" term="%22THERAPEUTICS%22">THERAPEUTICS</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects. Despite the teratogenicity of thalidomide and its derivatives lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-associated dysplasia. IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4CRBN. Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide. The structure establishes that CRBN is a substrate receptor within CRL4CRBN and enantioselectively binds IMiDs. Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4CRBN. Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4CRBN while the ligase complex is recruiting IKZF1 or IKZF3 for degradation. This dual activity implies that small molecules can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=ulh&AN=97379289
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/nature13527
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 49
    Subjects:
      – SubjectFull: ANTINEOPLASTIC agents
        Type: general
      – SubjectFull: THALIDOMIDE
        Type: general
      – SubjectFull: CARRIER proteins
        Type: general
      – SubjectFull: TERATOGENICITY testing
        Type: general
      – SubjectFull: MULTIPLE myeloma treatment
        Type: general
      – SubjectFull: THERAPEUTICS
        Type: general
    Titles:
      – TitleFull: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fischer, Eric S.
      – PersonEntity:
          Name:
            NameFull: Böhm, Kerstin
      – PersonEntity:
          Name:
            NameFull: Lydeard, John R.
      – PersonEntity:
          Name:
            NameFull: Yang, Haidi
      – PersonEntity:
          Name:
            NameFull: Stadler, Michael B.
      – PersonEntity:
          Name:
            NameFull: Cavadini, Simone
      – PersonEntity:
          Name:
            NameFull: Nagel, Jane
      – PersonEntity:
          Name:
            NameFull: Serluca, Fabrizio
      – PersonEntity:
          Name:
            NameFull: Acker, Vincent
      – PersonEntity:
          Name:
            NameFull: Lingaraju, Gondichatnahalli M.
      – PersonEntity:
          Name:
            NameFull: Tichkule, Ritesh B.
      – PersonEntity:
          Name:
            NameFull: Schebesta, Michael
      – PersonEntity:
          Name:
            NameFull: Forrester, William C.
      – PersonEntity:
          Name:
            NameFull: Schirle, Markus
      – PersonEntity:
          Name:
            NameFull: Hassiepen, Ulrich
      – PersonEntity:
          Name:
            NameFull: Ottl, Johannes
      – PersonEntity:
          Name:
            NameFull: Hild, Marc
      – PersonEntity:
          Name:
            NameFull: Beckwith, Rohan E. J.
      – PersonEntity:
          Name:
            NameFull: Harper, J. Wade
      – PersonEntity:
          Name:
            NameFull: Jenkins, Jeremy L.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 08
              Text: 8/6/2014
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-print
              Value: 00280836
          Numbering:
            – Type: volume
              Value: 512
            – Type: issue
              Value: 7512
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1